| Acinetobacter baumannii |
Acinetobacter baumannii |
Inhibition |
3.66 |
% |
10.6019/CHEMBL4513141 |
| Candida albicans |
Candida albicans |
Inhibition |
0.46 |
% |
10.6019/CHEMBL4513141 |
| Chlorocebus sabaeus |
Vero |
CC50 |
0.49 |
ug.mL-1 |
10.1021/jm9705869 |
| Chlorocebus sabaeus |
Vero |
CCID50 |
500.0 |
uM |
10.1016/0960-894X(95)00472-6 |
| Chlorocebus sabaeus |
Vero |
IC50 |
0.02 |
ug.mL-1 |
10.1021/jm9705869 |
| Chlorocebus sabaeus |
Vero |
IC50 |
nan |
nM |
10.1016/s0960-894x(00)00418-2 |
| Cricetulus griseus |
CHO |
Aberrant cells |
3.0 |
% |
10.1021/jm0495172 |
| Cricetulus griseus |
CHO |
Aberrant cells |
8.0 |
% |
10.1021/jm0495172 |
| Cricetulus griseus |
CHO |
Aberrant cells |
9.5 |
% |
10.1021/jm0495172 |
| Cricetulus griseus |
CHO |
Growth |
65.0 |
% |
10.1021/jm0495172 |
| Cricetulus griseus |
CHO |
Growth |
101.0 |
% |
10.1021/jm0495172 |
| Cricetulus griseus |
CHO |
Growth |
105.0 |
% |
10.1021/jm0495172 |
| Cryptococcus neoformans |
Cryptococcus neoformans |
Inhibition |
-0.26 |
% |
10.6019/CHEMBL4513141 |
| Drosophila melanogaster |
Deoxynucleoside kinase |
Activity |
2005.0 |
microM/min/mg |
10.1016/j.bmcl.2009.12.097 |
| Escherichia coli |
Escherichia coli |
Inhibition |
-9.44 |
% |
10.6019/CHEMBL4513141 |
| Feline leukemia virus |
Feline leukemia virus |
ED50 |
15.0 |
uM |
10.1021/np50082a020 |
| Hepacivirus hominis |
Hepatitis C virus |
EC50 |
nan |
nM |
10.1021/jm034265a |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
2300.0 |
nM |
10.1016/s0960-894x(00)00418-2 |
| Hepatitis B virus |
Hepatitis B virus |
EC50 |
nan |
nM |
10.1021/jm034265a |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
ATH-8 cell line |
Cytotoxicity |
0.0 |
% |
10.1021/jm00090a008 |
| Homo sapiens |
ATH-8 cell line |
Cytotoxicity |
0.0 |
% |
10.1021/jm00388a020 |
| Homo sapiens |
ATH-8 cell line |
Cytotoxicity |
1.0 |
% |
10.1021/jm00090a008 |
| Homo sapiens |
ATH-8 cell line |
Cytotoxicity |
6.0 |
% |
10.1021/jm00090a008 |
| Homo sapiens |
ATH-8 cell line |
Cytotoxicity |
9.0 |
% |
10.1021/jm00090a008 |
| Homo sapiens |
ATH-8 cell line |
Cytotoxicity |
30.0 |
% |
10.1021/jm00388a020 |
| Homo sapiens |
ATH-8 cell line |
ED50 |
0.2 |
uM |
10.1021/jm00391a003 |
| Homo sapiens |
ATH-8 cell line |
ID50 |
35.0 |
uM |
10.1021/jm00391a003 |
| Homo sapiens |
ATH-8 cell line |
MIC |
500.0 |
nM |
10.1021/jm00159a001 |
| Homo sapiens |
ATH-8 cell line |
Protection |
88.0 |
% |
10.1021/jm00090a008 |
| Homo sapiens |
ATH-8 cell line |
Protection |
93.0 |
% |
10.1021/jm00090a008 |
| Homo sapiens |
ATH-8 cell line |
Protection |
100.0 |
% |
10.1021/jm00090a008 |
| Homo sapiens |
ATH-8 cell line |
SI |
50.0 |
None |
10.1021/jm00159a001 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
AC50 |
300000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Bloom syndrome protein |
Potency |
199526.2 |
nM |
None |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
C8166 |
CD50 |
1000.0 |
uM |
10.1021/jm00170a015 |
| Homo sapiens |
C8166 |
IC50 |
125.0 |
nM |
10.1021/jm00170a015 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
CCRF-CEM |
EC50 |
189.0 |
nM |
10.1021/jm950797i |
| Homo sapiens |
CCRF-CEM |
EC50 |
300.0 |
nM |
10.1021/jm00090a008 |
| Homo sapiens |
CCRF-CEM |
ED50 |
1e-07 |
M |
10.1016/S0960-894X(01)81206-3 |
| Homo sapiens |
CCRF-CEM |
IC50 |
0.05 |
ug.mL-1 |
10.1021/jm00081a015 |
| Homo sapiens |
CCRF-CEM |
IC50 |
22.0 |
nM |
10.1021/jm00032a013 |
| Homo sapiens |
CCRF-CEM |
IC50 |
70.0 |
nM |
10.1021/jm9705723 |
| Homo sapiens |
CCRF-CEM |
IC50 |
10000.0 |
nM |
10.1021/jm9705723 |
| Homo sapiens |
CCRF-CEM |
IC50 |
28000.0 |
nM |
10.1021/jm00032a013 |
| Homo sapiens |
CCRF-CEM |
IC50 |
47340.0 |
nM |
10.1021/jm950797i |
| Homo sapiens |
CCRF-CEM |
IC50 |
70000.0 |
nM |
10.1021/jm00032a013 |
| Homo sapiens |
CCRF-CEM |
IC50 |
100000.0 |
nM |
10.1021/jm00032a013 |
| Homo sapiens |
CCRF-CEM |
IC50 |
120000.0 |
nM |
10.1021/jm00090a008 |
| Homo sapiens |
CCRF-CEM |
ID50 |
0.007 |
ug ml-1 |
10.1021/jm00170a017 |
| Homo sapiens |
CCRF-CEM |
ID50 |
0.04 |
uM |
10.1016/S0960-894X(01)81093-3 |
| Homo sapiens |
CCRF-CEM |
ID50 |
0.1 |
uM |
10.1016/S0960-894X(01)81093-3 |
| Homo sapiens |
CCRF-CEM |
ID50 |
5.0 |
uM |
10.1021/jm034265a |
| Homo sapiens |
CCRF-CEM |
Selectivity index |
53.0 |
None |
10.1021/jm9607921 |
| Homo sapiens |
CCRF-CEM |
TAI |
63.0 |
None |
10.1021/jm00081a015 |
| Homo sapiens |
CCRF-CEM |
TC25 |
5.3 |
ug ml-1 |
10.1021/jm00081a015 |
| Homo sapiens |
CCRF-CEM |
TCID50 |
1.3 |
ug ml-1 |
10.1021/jm00170a017 |
| Homo sapiens |
CCRF-CEM |
Toxicity |
0.1 |
None |
10.1016/S0960-894X(01)81093-3 |
| Homo sapiens |
CEM-SS |
CC50 |
10000.0 |
nM |
10.1021/jm9607921 |
| Homo sapiens |
CEM-SS |
CC50 |
16000.0 |
nM |
10.1016/j.ejmech.2021.113315 |
| Homo sapiens |
CEM-SS |
CC50 |
46000.0 |
nM |
10.1016/j.ejmech.2021.113315 |
| Homo sapiens |
CEM-SS |
CC50 |
nan |
None |
10.1016/j.bmc.2016.05.010 |
| Homo sapiens |
CEM-SS |
EC25 |
0.03 |
uM |
10.1016/s0960-894x(98)00380-1 |
| Homo sapiens |
CEM-SS |
EC25 |
5.0 |
uM |
10.1016/s0960-894x(98)00380-1 |
| Homo sapiens |
CEM-SS |
EC50 |
20.0 |
nM |
10.1016/s0960-894x(98)00380-1 |
| Homo sapiens |
CEM-SS |
EC50 |
50.0 |
nM |
10.1016/s0960-894x(98)00380-1 |
| Homo sapiens |
CEM-SS |
EC50 |
190.0 |
nM |
10.1016/s0960-894x(98)00380-1 |
| Homo sapiens |
CEM-SS |
EC50 |
33000.0 |
nM |
10.1021/jm991125l |
| Homo sapiens |
CEM-SS |
IC25 |
10.0 |
uM |
10.1016/s0960-894x(98)00380-1 |
| Homo sapiens |
CEM-SS |
IC50 |
5000.0 |
nM |
10.1016/s0960-894x(98)00380-1 |
| Homo sapiens |
CEM-SS |
IC50 |
61000.0 |
nM |
10.1021/np5006696 |
| Homo sapiens |
CEM-TK(-) |
CC50 |
7000.0 |
nM |
10.1016/j.ejmech.2021.113315 |
| Homo sapiens |
CEM-TK(-) |
CC50 |
8300.0 |
nM |
10.1016/j.ejmech.2021.113315 |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Chromobox protein homolog 1 |
Potency |
89125.1 |
nM |
None |
| Homo sapiens |
C-X-C chemokine receptor type 4 |
EC50 |
88.0 |
nM |
10.1016/s0960-894x(01)00323-7 |
| Homo sapiens |
C-X-C chemokine receptor type 4 |
IC50 |
nan |
nM |
10.1016/s0960-894x(01)00323-7 |
| Homo sapiens |
C-X-C chemokine receptor type 4 |
IC50 |
nan |
nM |
10.1016/s0960-894x(02)00041-0 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cytochrome P450 2C9 |
FC |
1.0 |
None |
10.1016/j.bmcl.2016.06.088 |
| Homo sapiens |
Cytochrome P450 2D6 |
FC |
1.0 |
None |
10.1016/j.bmcl.2016.06.088 |
| Homo sapiens |
Cytochrome P450 3A4 |
FC |
1.0 |
None |
10.1016/j.bmcl.2016.06.088 |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Deoxycytidine kinase |
Ki |
360000.0 |
nM |
10.1021/jm00163a043 |
| Homo sapiens |
Deoxycytidine kinase |
Ki |
1000000.0 |
nM |
10.1021/jm00163a043 |
| Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
5.0 |
nM |
None |
| Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
20.0 |
nM |
None |
| Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
DNA polymerase beta |
Inhibition |
nan |
% |
10.1021/acs.jnatprod.5b00621 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Galactocerebrosidase |
Potency |
707.9 |
nM |
None |
| Homo sapiens |
Geminin |
Potency |
103.2 |
nM |
None |
| Homo sapiens |
Ghrelin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
H9 |
IC50 |
500000.0 |
nM |
10.1016/0960-894X(96)00096-0 |
| Homo sapiens |
HEL |
MCC |
250000.0 |
nM |
10.1016/j.bmc.2018.05.034 |
| Homo sapiens |
HEL |
MCC |
250000.0 |
nM |
10.1016/j.bmcl.2018.09.019 |
| Homo sapiens |
HEL |
MCC |
250000.0 |
nM |
10.1016/j.ejmech.2016.10.002 |
| Homo sapiens |
HeLa |
IC50 |
38000.0 |
nM |
10.1016/0960-894X(95)00472-6 |
| Homo sapiens |
Hepatoma cell line |
ED50 |
0.01 |
uM |
10.1021/jm00032a013 |
| Homo sapiens |
Hepatoma cell line |
ED50 |
2.8 |
uM |
10.1021/jm00032a013 |
| Homo sapiens |
Hepatoma cell line |
ED50 |
5.0 |
uM |
10.1021/jm00032a013 |
| Homo sapiens |
HepG2 |
Activity |
0.3 |
% |
10.1128/aac.00392-09 |
| Homo sapiens |
HepG2 |
Activity |
3.0 |
% |
10.1128/aac.00794-10 |
| Homo sapiens |
HepG2 |
Activity |
9.5 |
% |
10.1021/acs.jmedchem.7b00067 |
| Homo sapiens |
HepG2 |
Activity |
30.0 |
% |
10.1128/aac.00794-10 |
| Homo sapiens |
HepG2 |
Activity |
170.0 |
% |
10.1128/aac.00392-09 |
| Homo sapiens |
HepG2 |
Activity |
170.0 |
% |
10.1128/aac.00794-10 |
| Homo sapiens |
HepG2 |
Activity |
200.0 |
% |
10.1021/acs.jmedchem.8b01300 |
| Homo sapiens |
HepG2 |
Activity |
220.0 |
% |
10.1021/jm501874e |
| Homo sapiens |
HepG2 |
Activity |
330.0 |
% |
10.1021/acs.jmedchem.7b00067 |
| Homo sapiens |
HepG2 |
Activity |
nan |
None |
10.1007/s00044-011-9616-2 |
| Homo sapiens |
HepG2 |
Activity |
nan |
None |
10.1021/jm501874e |
| Homo sapiens |
HepG2 |
Activity |
nan |
None |
10.1128/aac.00794-10 |
| Homo sapiens |
HepG2 |
CC50 |
10000.0 |
nM |
10.1021/jm501874e |
| Homo sapiens |
HepG2 |
EC50 |
1400.0 |
nM |
10.1016/S0960-894X(97)00422-8 |
| Homo sapiens |
HepG2 |
EC50 |
1500.0 |
nM |
10.1016/S0960-894X(97)00001-2 |
| Homo sapiens |
HepG2 |
EC50 |
3200.0 |
nM |
10.1016/S0960-894X(97)00001-2 |
| Homo sapiens |
HepG2 |
EC50 |
nan |
nM |
10.1021/jm0309708 |
| Homo sapiens |
HepG2 |
EC90 |
6.9 |
uM |
10.1016/S0960-894X(97)00001-2 |
| Homo sapiens |
HepG2 |
EC90 |
8.4 |
uM |
10.1016/S0960-894X(97)00422-8 |
| Homo sapiens |
HepG2 |
EC90 |
10.0 |
uM |
10.1016/S0960-894X(97)00001-2 |
| Homo sapiens |
HepG2 |
IC50 |
2.1 |
ug.mL-1 |
10.1021/jm00020a009 |
| Homo sapiens |
HepG2 |
IC50 |
1400.0 |
nM |
10.1021/jm9705723 |
| Homo sapiens |
HepG2 |
IC50 |
10000.0 |
nM |
10.1021/acs.jmedchem.7b00067 |
| Homo sapiens |
HepG2 |
IC50 |
10000.0 |
nM |
10.1021/acs.jmedchem.8b01300 |
| Homo sapiens |
HepG2 |
IC50 |
37000.0 |
nM |
10.1016/s0960-894x(00)00418-2 |
| Homo sapiens |
HepG2 |
IC50 |
100000.0 |
nM |
10.1016/0960-894X(95)00472-6 |
| Homo sapiens |
HepG2 |
IC50 |
252000.0 |
nM |
10.1016/S0960-894X(97)00422-8 |
| Homo sapiens |
HepG2 |
Inhibition |
50.0 |
% |
10.1021/acs.jmedchem.8b01300 |
| Homo sapiens |
HepG2 |
Inhibition |
53.0 |
% |
10.1021/acs.jmedchem.7b00067 |
| Homo sapiens |
HepG2 |
Inhibition |
61.39 |
% |
10.1128/aac.00392-09 |
| Homo sapiens |
HepG2 |
Inhibition |
84.0 |
% |
10.1021/acs.jmedchem.8b01300 |
| Homo sapiens |
HepG2 |
Inhibition |
96.0 |
% |
10.1021/acs.jmedchem.7b00067 |
| Homo sapiens |
HepG2 |
Inhibition |
99.88 |
% |
10.1128/aac.00392-09 |
| Homo sapiens |
HepG2 |
Relative level |
1.0 |
None |
10.1016/S0960-894X(97)00422-8 |
| Homo sapiens |
HepG2 |
Relative level |
6.0 |
None |
10.1016/S0960-894X(97)00422-8 |
| Homo sapiens |
HepG2 |
Relative level |
87.0 |
None |
10.1016/S0960-894X(97)00422-8 |
| Homo sapiens |
HepG2 |
Relative level |
88.0 |
None |
10.1016/S0960-894X(97)00422-8 |
| Homo sapiens |
HepG2 |
Relative level |
90.0 |
None |
10.1016/S0960-894X(97)00422-8 |
| Homo sapiens |
HepG2 |
Relative level |
91.0 |
None |
10.1016/S0960-894X(97)00422-8 |
| Homo sapiens |
HepG2 |
Relative level |
94.0 |
None |
10.1016/S0960-894X(97)00422-8 |
| Homo sapiens |
HepG2 |
TC50 |
64.0 |
ug ml-1 |
10.1021/jm00020a009 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-12.48 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
1.78 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
HL-60 |
IC50 |
100000.0 |
nM |
10.1021/jm00170a016 |
| Homo sapiens |
Homo sapiens |
CL |
1.1 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
CL |
5.6 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
CL_renal |
4.5 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fa |
1.0 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
F_fraction |
0.88 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fg |
0.93 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fh |
0.95 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Vdss |
0.54 |
L.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
MAP kinase ERK2 |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
125.9 |
nM |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
MT2 |
CC50 |
4000.0 |
nM |
10.1021/ml4002979 |
| Homo sapiens |
MT2 |
EC50 |
0.29 |
ug.mL-1 |
10.1021/jm00163a004 |
| Homo sapiens |
MT2 |
EC50 |
331.0 |
nM |
10.1021/jm950797i |
| Homo sapiens |
MT2 |
EC50 |
900.0 |
nM |
10.1021/jm950797i |
| Homo sapiens |
MT2 |
EC50 |
994.0 |
nM |
10.1021/jm950797i |
| Homo sapiens |
MT2 |
EC50 |
1562.0 |
nM |
10.1021/jm950797i |
| Homo sapiens |
MT2 |
ED50 |
1.5 |
uM |
10.1021/jm00032a013 |
| Homo sapiens |
MT2 |
ED50 |
5.0 |
uM |
10.1021/jm00032a013 |
| Homo sapiens |
MT2 |
ED50 |
100.0 |
uM |
10.1021/jm00032a013 |
| Homo sapiens |
MT2 |
IC50 |
0.44 |
ug.mL-1 |
10.1021/jm00081a015 |
| Homo sapiens |
MT2 |
IC50 |
44.0 |
ug.mL-1 |
10.1021/jm00163a004 |
| Homo sapiens |
MT2 |
IC50 |
83800.0 |
nM |
10.1021/jm950797i |
| Homo sapiens |
MT2 |
IC50 |
134930.0 |
nM |
10.1021/jm950797i |
| Homo sapiens |
MT2 |
IC50 |
212100.0 |
nM |
10.1021/jm950797i |
| Homo sapiens |
MT2 |
IC50 |
258970.0 |
nM |
10.1021/jm950797i |
| Homo sapiens |
MT2 |
IC50 |
nan |
nM |
10.1016/s0960-894x(00)00418-2 |
| Homo sapiens |
MT2 |
ID50 |
70.0 |
uM |
10.1021/jm034265a |
| Homo sapiens |
MT2 |
TAI |
52.0 |
None |
10.1021/jm00081a015 |
| Homo sapiens |
MT2 |
TC25 |
9.8 |
ug ml-1 |
10.1021/jm00081a015 |
| Homo sapiens |
MT4 |
CC50 |
10.66 |
ug.mL-1 |
10.1016/j.bmc.2011.05.026 |
| Homo sapiens |
MT4 |
CC50 |
11.0 |
ug.mL-1 |
10.1021/np020234r |
| Homo sapiens |
MT4 |
CC50 |
20.0 |
ug.mL-1 |
10.1007/s00044-013-0567-7 |
| Homo sapiens |
MT4 |
CC50 |
14000.0 |
nM |
10.1016/s0960-894x(01)00323-7 |
| Homo sapiens |
MT4 |
CC50 |
30000.0 |
nM |
10.1021/jm00093a003 |
| Homo sapiens |
MT4 |
CC50 |
40000.0 |
nM |
10.1021/jm00105a055 |
| Homo sapiens |
MT4 |
CC50 |
40000.0 |
nM |
10.1021/jm00132a002 |
| Homo sapiens |
MT4 |
CC50 |
48000.0 |
nM |
10.1016/s0960-894x(02)00041-0 |
| Homo sapiens |
MT4 |
CC50 |
75200.0 |
nM |
10.1016/j.ejmech.2013.01.015 |
| Homo sapiens |
MT4 |
CC50 |
94000.0 |
nM |
10.1016/j.ejmech.2011.08.011 |
| Homo sapiens |
MT4 |
CC50 |
94690.0 |
nM |
10.1016/j.bmc.2011.07.023 |
| Homo sapiens |
MT4 |
CC50 |
94690.0 |
nM |
10.1016/j.bmc.2012.04.030 |
| Homo sapiens |
MT4 |
CC50 |
94690.0 |
nM |
10.1039/C3MD00028A |
| Homo sapiens |
MT4 |
CC50 |
94700.0 |
nM |
10.1016/j.bmc.2013.08.040 |
| Homo sapiens |
MT4 |
CC50 |
94700.0 |
nM |
10.1016/j.bmc.2016.05.010 |
| Homo sapiens |
MT4 |
CC50 |
94700.0 |
nM |
10.1016/j.ejmech.2012.02.019 |
| Homo sapiens |
MT4 |
CC50 |
94700.0 |
nM |
10.1039/C3MD00247K |
| Homo sapiens |
MT4 |
CC50 |
95000.0 |
nM |
10.1016/j.bmc.2012.07.026 |
| Homo sapiens |
MT4 |
CC50 |
95000.0 |
nM |
10.1016/j.bmc.2012.09.058 |
| Homo sapiens |
MT4 |
CC50 |
95000.0 |
nM |
10.1016/j.bmc.2013.09.009 |
| Homo sapiens |
MT4 |
CC50 |
95000.0 |
nM |
10.1016/j.bmcl.2012.09.062 |
| Homo sapiens |
MT4 |
CC50 |
100000.0 |
nM |
10.1016/j.ejmech.2021.113315 |
| Homo sapiens |
MT4 |
CC50 |
100000.0 |
nM |
10.1021/jm991125l |
| Homo sapiens |
MT4 |
CC50 |
130000.0 |
nM |
10.1016/j.ejmech.2021.113315 |
| Homo sapiens |
MT4 |
CC50 |
141000.0 |
nM |
10.1021/jm0309708 |
| Homo sapiens |
MT4 |
CC50 |
180000.0 |
nM |
10.1016/j.ejmech.2021.113315 |
| Homo sapiens |
MT4 |
CC50 |
324800.0 |
nM |
10.1016/j.bmcl.2013.12.093 |
| Homo sapiens |
MT4 |
CD50 |
40.0 |
uM |
10.1021/jm00168a046 |
| Homo sapiens |
MT4 |
EC50 |
236.0 |
nM |
10.1021/jm00170a016 |
| Homo sapiens |
MT4 |
EC50 |
240.0 |
nM |
10.1021/jm00170a016 |
| Homo sapiens |
MT4 |
EC50 |
300.0 |
nM |
10.1021/jm00132a002 |
| Homo sapiens |
MT4 |
EC50 |
1040.0 |
nM |
10.1021/jm0309708 |
| Homo sapiens |
MT4 |
EC50 |
2400.0 |
nM |
10.1021/jm991125l |
| Homo sapiens |
MT4 |
EC50 |
33000.0 |
nM |
10.1016/s0960-894x(02)00041-0 |
| Homo sapiens |
MT4 |
ED50 |
0.011 |
ug ml-1 |
10.1021/jm00088a026 |
| Homo sapiens |
MT4 |
IC50 |
1000.0 |
nM |
10.1021/jm00057a002 |
| Homo sapiens |
MT4 |
IC50 |
1600.0 |
nM |
10.1016/s0960-894x(04)00205-7 |
| Homo sapiens |
MT4 |
IC50 |
313000.0 |
nM |
10.1021/jm00170a016 |
| Homo sapiens |
MT4 |
ID50 |
27.0 |
ug ml-1 |
10.1021/jm00088a026 |
| Homo sapiens |
MT4 |
Protection |
10.0 |
% |
10.1021/jm00391a003 |
| Homo sapiens |
MT4 |
Protection |
40.0 |
% |
10.1021/jm00391a003 |
| Homo sapiens |
MT4 |
Protection |
90.0 |
% |
10.1021/jm00391a003 |
| Homo sapiens |
MT4 |
Selectivity index |
120.0 |
None |
10.1021/jm00168a046 |
| Homo sapiens |
MT4 |
Selectivity index |
133.0 |
None |
10.1021/jm00105a055 |
| Homo sapiens |
MT4 |
SI |
135.0 |
None |
10.1021/jm0309708 |
| Homo sapiens |
MT4 |
Toxicity |
10.0 |
% |
10.1021/jm00391a003 |
| Homo sapiens |
MT4 |
Toxicity |
90.0 |
% |
10.1021/jm00391a003 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Nuclear factor NF-kappa-B p105 subunit |
Potency |
794.3 |
nM |
None |
| Homo sapiens |
PBMC |
CC50 |
nan |
nM |
10.1021/jm0309708 |
| Homo sapiens |
PBMC |
EC50 |
nan |
nM |
10.1021/jm0309708 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Prelamin-A/C |
Potency |
100.0 |
nM |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serum albumin |
Kd |
44000.0 |
nM |
10.1016/j.bmcl.2015.05.099 |
| Homo sapiens |
Solute carrier family 22 member 6 |
Activity |
nan |
None |
10.1038/nrd3028 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thyroid hormone receptor beta-1 |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
7499.3 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
8199.5 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
9200.0 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
10593.1 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
13335.9 |
nM |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Human adenovirus 2 |
Human adenovirus 2 |
EC50 |
7200.0 |
nM |
10.1016/j.ejmech.2016.10.002 |
| Human adenovirus 2 |
Human adenovirus 2 |
EC50 |
10000.0 |
nM |
10.1016/j.bmc.2018.05.034 |
| Human adenovirus 2 |
Human adenovirus 2 |
EC50 |
10000.0 |
nM |
10.1016/j.ejmech.2019.111739 |
| Human adenovirus 2 |
Human adenovirus 2 |
EC50 |
50000.0 |
nM |
10.1016/j.bmcl.2018.09.019 |
| Human adenovirus 2 |
Human adenovirus 2 |
IC50 |
3300.0 |
nM |
10.1016/j.bmc.2008.11.075 |
| Human alphaherpesvirus 1 |
Human alphaherpesvirus 1 |
EC50 |
nan |
nM |
10.1016/s0960-894x(00)00418-2 |
| Human alphaherpesvirus 1 |
Human alphaherpesvirus 1 |
EC50 |
nan |
nM |
10.1021/jm034265a |
| Human alphaherpesvirus 2 |
Human alphaherpesvirus 2 |
EC50 |
nan |
nM |
10.1016/s0960-894x(00)00418-2 |
| Human gammaherpesvirus 4 |
Human gammaherpesvirus 4 |
EC50 |
nan |
nM |
10.1021/jm034265a |
| Human immunodeficiency virus |
Human immunodeficiency virus |
EC50 |
300.0 |
nM |
10.1021/jm00105a055 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
0.1 |
ug.mL-1 |
10.1021/np020234r |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
1.0 |
nM |
10.1021/np0003995 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
9.0 |
nM |
10.1016/j.ejmech.2021.113315 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
10.0 |
nM |
10.1016/j.ejmech.2021.113315 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
15.0 |
nM |
10.1016/j.ejmech.2021.113315 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
16.0 |
nM |
10.1016/j.ejmech.2021.113315 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
30.0 |
nM |
10.1016/0960-894X(96)00096-0 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
67.0 |
nM |
10.1016/j.ejmech.2021.113315 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
79.0 |
nM |
10.1021/np5006696 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
83.0 |
nM |
10.1016/j.ejmech.2021.113315 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
190.0 |
nM |
10.1021/jm9607921 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
400.0 |
nM |
10.1016/j.ejmech.2013.01.015 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
460.0 |
nM |
10.1016/j.bmc.2013.08.040 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
570.0 |
nM |
10.1039/C3MD00247K |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
750.0 |
nM |
10.1016/j.ejmech.2011.08.011 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
910.0 |
nM |
10.1021/jm00093a003 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
1000.0 |
nM |
10.1016/j.bmc.2012.09.058 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
1000.0 |
nM |
10.1016/j.bmcl.2012.09.062 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
1040.0 |
nM |
10.1039/C3MD00028A |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
1041.6 |
nM |
10.1016/j.ejmech.2012.02.019 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
1200.0 |
nM |
10.1016/j.ejmech.2021.113315 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
1370.0 |
nM |
10.1016/j.bmc.2016.05.010 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
1390.0 |
nM |
10.1016/j.bmc.2012.07.026 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
1394.28 |
nM |
10.1016/j.bmc.2012.04.030 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
1400.0 |
nM |
10.1016/j.bmc.2013.09.009 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
1468.0 |
nM |
10.1016/j.bmc.2011.07.023 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
2000.0 |
nM |
10.1016/j.ejmech.2021.113315 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
nan |
nM |
10.1016/s0960-894x(00)00418-2 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
nan |
None |
10.1016/j.bmc.2013.08.040 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
nan |
None |
10.1016/j.bmc.2016.05.010 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
nan |
None |
10.1039/C3MD00247K |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
ED50 |
0.3 |
uM |
10.1021/jm00168a046 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
IC50 |
0.043 |
ug.mL-1 |
10.1016/j.bmc.2011.05.026 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
IC50 |
0.16 |
ug.mL-1 |
10.1007/s00044-013-0567-7 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
IC50 |
130.0 |
nM |
10.1128/aac.00392-09 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
IC50 |
200.0 |
nM |
10.1128/aac.00392-09 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
IC50 |
1000.0 |
nM |
10.1016/j.bmcl.2013.12.093 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
IC50 |
1400.0 |
nM |
10.1128/aac.00392-09 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus type 1 reverse transcriptase |
Activity |
nan |
None |
10.1021/jm00042a005 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus type 1 reverse transcriptase |
CC50 |
34000.0 |
nM |
10.1021/jm991125l |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus type 1 reverse transcriptase |
EC50 |
31.0 |
nM |
10.1021/jm991125l |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus type 1 reverse transcriptase |
IC50 |
nan |
None |
10.1021/np5006696 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus type 1 reverse transcriptase |
Ki |
51.0 |
nM |
10.1021/jm040101y |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
EC50 |
0.1 |
ug.mL-1 |
10.1021/np020234r |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
EC50 |
400.0 |
nM |
10.1016/j.ejmech.2013.01.015 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
EC50 |
690.0 |
nM |
10.1021/jm00093a003 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
EC50 |
880.0 |
nM |
10.1016/j.ejmech.2011.08.011 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
EC50 |
1280.0 |
nM |
10.1039/C3MD00028A |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
EC50 |
1300.0 |
nM |
10.1016/j.bmc.2012.09.058 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
EC50 |
1300.0 |
nM |
10.1016/j.bmcl.2012.09.062 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
EC50 |
1560.0 |
nM |
10.1016/j.bmc.2011.07.023 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
EC50 |
1610.0 |
nM |
10.1039/C3MD00247K |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
EC50 |
1670.0 |
nM |
10.1016/j.bmc.2012.04.030 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
EC50 |
1700.0 |
nM |
10.1016/j.bmc.2012.07.026 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
EC50 |
1700.0 |
nM |
10.1016/j.bmc.2013.08.040 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
EC50 |
nan |
None |
10.1016/j.bmc.2014.01.054 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC50 |
0.04 |
ug.mL-1 |
10.1016/j.bmc.2011.05.026 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC50 |
0.19 |
ug.mL-1 |
10.1007/s00044-013-0567-7 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC50 |
500.0 |
nM |
10.1016/j.bmcl.2013.12.093 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC50 |
1900.0 |
nM |
10.1016/j.bmcl.2013.12.093 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
Inhibition |
8.0 |
% |
10.6019/CHEMBL4513141 |
| Moloney murine leukemia virus |
Moloney murine leukemia virus |
ED50 |
4.0 |
uM |
10.1021/jm00385a033 |
| Murine leukemia virus |
Murine leukemia virus |
MIC50 |
0.74 |
ug.mL-1 |
10.1021/jm00093a023 |
| Murine leukemia virus |
Murine leukemia virus |
TD50 |
100.0 |
ug ml-1 |
10.1021/jm00093a023 |
| Mus musculus |
Monoamine oxidase A |
Activity |
nan |
None |
10.1021/jm800656v |
| Mus musculus |
Monoamine oxidase B |
Activity |
nan |
None |
10.1021/jm800656v |
| Mus musculus |
Mus musculus |
EC50 |
13800.0 |
nM |
10.1021/jm00105a064 |
| Mus musculus |
Mus musculus |
EC50 |
23000.0 |
nM |
10.1021/jm00105a064 |
| Mus musculus |
Mus musculus |
IC50 |
100000.0 |
nM |
10.1021/jm00105a064 |
| Mycobacterium avium |
Mycobacterium avium |
Inhibition |
0.0 |
% |
10.1021/jm070391t |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
Inhibition |
0.0 |
% |
10.1021/jm070391t |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
EC50 |
nan |
nM |
10.1021/jm034265a |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
18526.0 |
nM |
None |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Inhibition |
1.57 |
% |
10.6019/CHEMBL4513141 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
H9c2 |
Activity |
nan |
None |
10.1128/aac.00039-07 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
41000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
42000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
42700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
43000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
43300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
44300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
291.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
300.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
323.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
366.5 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
380.5 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
42.5 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
46.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
49.17 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
49.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
63.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
78.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
78.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
86.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
87.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
95.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
101.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BASOLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BASOLE |
0.17 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BASOLE |
0.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
0.833 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
1.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
153.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
156.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
170.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
183.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
98.33 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
99.0 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
99.67 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
101.0 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
102.83 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
103.67 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
633.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
680.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
706.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
746.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
783.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
790.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
320.83 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
442.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
509.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
672.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
865.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
891.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
22330000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
22670000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
24170000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
24330000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Concentration |
109.0 |
nM min ml-1 |
10.1021/jm00057a002 |
| Rattus norvegicus |
Rattus norvegicus |
Concentration |
126.0 |
nM min ml-1 |
10.1021/jm00057a002 |
| Rattus norvegicus |
Rattus norvegicus |
Concentration |
176.0 |
nM min ml-1 |
10.1021/jm00057a002 |
| Rattus norvegicus |
Rattus norvegicus |
Concentration |
408.0 |
nM min ml-1 |
10.1021/jm00057a002 |
| Rattus norvegicus |
Rattus norvegicus |
Concentration |
749.0 |
nM min ml-1 |
10.1021/jm00057a002 |
| Rattus norvegicus |
Rattus norvegicus |
Concentration |
3099.0 |
nM min ml-1 |
10.1021/jm00057a002 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
2.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
3.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.83 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
1.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
1.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1290.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1380.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1396.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1408.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1413.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1470.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
42.4 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
42.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
43.12 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
43.13 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
44.03 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
45.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
141800.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
142700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
143300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
146300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
147300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
150000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
210.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
216.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
255.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
289.83 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
673.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
744.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
8.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
8.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
8.83 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
9.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
9.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
70.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
72.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
75.17 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
80.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
80.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
81.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
19.83 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
20.0 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
20.1 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
20.25 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
20.35 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
20.4 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
329500.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
333700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
334000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
335700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
337300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
339500.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
59.27 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
59.43 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
59.93 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
60.37 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
60.7 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
61.43 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
2.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
2.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
2.83 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
15.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
16.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
21.17 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
24.5 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
25.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
91.2 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
93.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
94.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
95.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
95.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
102.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
957670.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1028500.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1049330.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1093170.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1184000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1274000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
5.55 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
5.65 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
5.67 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
5.77 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
5.83 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
5.95 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
61000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
61700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
62300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
62700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
63000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
64000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
7020000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
7030000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
7160000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
7200000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
7410000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
7450000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
139.0 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
140.67 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
141.0 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
143.67 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
144.17 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
146.33 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
8.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
9.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
9.8 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
10.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
12.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
13.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
9050.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
9430.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
9630.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
9770.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
10430.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
11230.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Solute carrier family 22 member 6 |
Activity |
nan |
None |
None |
| Rattus norvegicus |
Solute carrier family 22 member 7 |
Km |
3000000.0 |
nM |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
946.6 |
nM |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
1412.5 |
nM |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
1778.3 |
nM |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
37685.8 |
nM |
None |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
5.14 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
25.63 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.1927 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.04 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.0 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.17 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
0.1721 |
None |
10.1101/2020.04.03.023846 |
| Staphylococcus aureus |
Staphylococcus aureus |
Inhibition |
4.24 |
% |
10.6019/CHEMBL4513141 |
| None |
ADMET |
Activity |
1.0 |
% |
10.1128/aac.00039-07 |
| None |
ADMET |
Activity |
11.0 |
% |
10.1128/aac.00039-07 |
| None |
ADMET |
Activity |
15.0 |
% |
10.1128/aac.00039-07 |
| None |
ADMET |
Activity |
50.0 |
% |
10.1128/aac.00914-09 |
| None |
ADMET |
Activity |
nan |
None |
10.1128/aac.00039-07 |
| None |
ADMET |
Activity |
nan |
None |
10.1128/aac.00914-09 |
| None |
ADMET |
CC50 |
10000.0 |
nM |
10.1021/jm991125l |
| None |
ADMET |
CC50 |
178800.0 |
nM |
10.1016/j.bmcl.2013.12.093 |
| None |
ADMET |
CC50 |
233000.0 |
nM |
10.1016/S0960-894X(97)00001-2 |
| None |
ADMET |
CC50 |
nan |
nM |
10.1016/s0960-894x(01)00323-7 |
| None |
ADMET |
CL |
5.6 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
delta logD |
0.0 |
None |
10.1021/jm0000564 |
| None |
ADMET |
EC50 |
16.0 |
nM |
10.1021/jm991125l |
| None |
ADMET |
EC50 |
70.0 |
nM |
10.1021/jm991125l |
| None |
ADMET |
F |
20.0 |
% |
10.1021/jm0000564 |
| None |
ADMET |
F |
80.0 |
% |
10.1021/acs.jmedchem.1c00790 |
| None |
ADMET |
F |
80.0 |
% |
10.1021/jm0000564 |
| None |
ADMET |
ID50 |
1990.0 |
uM |
10.1021/np50082a020 |
| None |
ADMET |
log10(%HIA +10) |
1.978 |
None |
10.1016/j.ejmech.2010.11.005 |
| None |
ADMET |
MRT |
1.6 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Ratio |
175.0 |
None |
10.1021/jm00391a003 |
| None |
ADMET |
Ratio CC50/EC50 |
74.0 |
None |
10.1039/C3MD00028A |
| None |
ADMET |
Ratio CC50/EC50 |
83.0 |
None |
10.1016/j.ejmech.2021.113315 |
| None |
ADMET |
Ratio CC50/EC50 |
90.0 |
None |
10.1016/j.ejmech.2021.113315 |
| None |
ADMET |
Ratio CC50/EC50 |
93.0 |
None |
10.1039/C3MD00028A |
| None |
ADMET |
Ratio CC50/EC50 |
239.0 |
None |
10.1016/j.ejmech.2021.113315 |
| None |
ADMET |
Ratio CC50/EC50 |
467.0 |
None |
10.1016/j.ejmech.2021.113315 |
| None |
ADMET |
Ratio CC50/EC50 |
922.0 |
None |
10.1016/j.ejmech.2021.113315 |
| None |
ADMET |
Ratio CC50/EC50 |
2875.0 |
None |
10.1016/j.ejmech.2021.113315 |
| None |
ADMET |
Ratio CC50/EC50 |
4600.0 |
None |
10.1016/j.ejmech.2021.113315 |
| None |
ADMET |
Ratio CC50/EC50 |
15660.0 |
None |
10.1016/j.ejmech.2021.113315 |
| None |
ADMET |
Solubility |
78000.0 |
ug.mL-1 |
10.1021/jm00089a008 |
| None |
ADMET |
T1/2 |
1.2 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
T1/2 |
22.7 |
None |
10.1021/jm00057a002 |
| None |
ADMET |
Therapeutic index |
16667.0 |
None |
10.1016/0960-894X(96)00096-0 |
| None |
ADMET |
TI |
26.0 |
None |
10.1016/s0960-894x(98)00380-1 |
| None |
ADMET |
TI |
93.0 |
None |
10.1021/jm950797i |
| None |
ADMET |
TI |
100.0 |
None |
10.1016/s0960-894x(98)00380-1 |
| None |
ADMET |
TI |
135.14 |
TD50/MIC50 |
10.1021/jm00093a023 |
| None |
ADMET |
TI |
152.0 |
None |
10.1021/jm00163a004 |
| None |
ADMET |
TI |
166.0 |
None |
10.1021/jm950797i |
| None |
ADMET |
TI |
200.0 |
None |
10.1021/np0003995 |
| None |
ADMET |
TI |
213.0 |
None |
10.1021/jm950797i |
| None |
ADMET |
TI |
250.0 |
None |
10.1016/s0960-894x(98)00380-1 |
| None |
ADMET |
TI |
250.0 |
None |
10.1021/jm950797i |
| None |
ADMET |
TI |
333.0 |
None |
10.1016/s0960-894x(98)00380-1 |
| None |
ADMET |
TI |
380.0 |
None |
10.1021/jm00090a008 |
| None |
ADMET |
TI |
408.0 |
None |
10.1021/jm950797i |
| None |
ADMET |
TI |
2450.0 |
None |
10.1021/jm00088a026 |
| None |
ADMET |
Vdss |
0.54 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Index Value |
2.9 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Active |
1.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Marginal |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Index Value |
1.4 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx1000865 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1124/dmd.110.035113 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
5.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
LDH Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Index Value |
1.4 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LTKB_BD DILI severity score |
8.0 |
None |
10.1016/j.drudis.2011.05.007 |
| None |
Hepatotoxicity |
SGOT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Index Value |
5.7 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Index Value |
2.9 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
NON-PROTEIN TARGET |
CC50 |
20.0 |
ug.mL-1 |
10.1016/j.ejmech.2016.05.017 |
| None |
NON-PROTEIN TARGET |
CC50 |
219000.0 |
nM |
10.1021/jm00047a013 |
| None |
NON-PROTEIN TARGET |
EC50 |
0.16 |
ug.mL-1 |
10.1016/j.ejmech.2016.05.017 |
| None |
NON-PROTEIN TARGET |
EC50 |
0.19 |
ug.mL-1 |
10.1016/j.ejmech.2016.05.017 |
| None |
NON-PROTEIN TARGET |
EC50 |
7200.0 |
nM |
10.1016/j.bmcl.2016.09.071 |
| None |
NON-PROTEIN TARGET |
ED50 |
2.2 |
uM |
10.1021/jm00089a008 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
8.5 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
5.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
14.9 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
IC50 |
1000000.0 |
nM |
10.1021/jm00089a008 |
| None |
NON-PROTEIN TARGET |
MCC |
250000.0 |
nM |
10.1016/j.bmcl.2016.09.071 |
| None |
NON-PROTEIN TARGET |
Ratio CC50/EC50 |
69.0 |
None |
10.1016/j.bmc.2016.05.010 |
| None |
NON-PROTEIN TARGET |
Ratio CC50/EC50 |
nan |
None |
10.1016/j.bmc.2016.05.010 |
| None |
No relevant target |
LogD |
-1.33 |
None |
10.1021/jm0000564 |
| None |
No relevant target |
LogD |
3.2 |
None |
10.1021/jm0000564 |
| None |
No relevant target |
LogP |
-1.33 |
None |
10.1021/jm00090a008 |
| None |
No relevant target |
LogP |
-1.33 |
None |
10.1021/jm00109a018 |
| None |
No relevant target |
LogP |
-0.58 |
None |
10.1021/jm0309708 |
| None |
No relevant target |
LogP |
0.073 |
None |
10.1021/jm00089a008 |
| None |
No relevant target |
P |
0.17 |
None |
10.1021/jm00163a043 |
| None |
No relevant target |
pKa |
4.42 |
None |
10.1021/jm00089a008 |
| None |
No relevant target |
pKa |
nan |
None |
10.1021/jm0000564 |
| None |
Unchecked |
Ac50 |
2.239 |
uM |
None |
| None |
Unchecked |
Ac50 |
3.162 |
uM |
None |
| None |
Unchecked |
Ac50 |
3.548 |
uM |
None |
| None |
Unchecked |
AC50 |
2238.7 |
nM |
None |
| None |
Unchecked |
AC50 |
3162.3 |
nM |
None |
| None |
Unchecked |
AC50 |
3548.1 |
nM |
None |
| None |
Unchecked |
EC50 |
800.0 |
nM |
10.1021/jm034265a |
| None |
Unchecked |
EC50 |
1300.0 |
nM |
10.1021/jm00047a013 |
| None |
Unchecked |
EC50 |
2100.0 |
nM |
10.1021/jm00047a013 |
| None |
Unchecked |
EC50 |
nan |
nM |
10.1021/jm034265a |
| None |
Unchecked |
EC90 |
8.1 |
uM |
10.1021/jm00047a013 |
| None |
Unchecked |
EC90 |
12.0 |
uM |
10.1021/jm00047a013 |
| None |
Unchecked |
Hepatotoxicity (acute) |
4.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
3.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
2.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
nan |
None |
10.1016/j.bmc.2016.05.010 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1038/nchembio873 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1128/aac.00914-09 |
| None |
Unchecked |
MCC |
250000.0 |
nM |
10.1016/j.ejmech.2019.111739 |
| None |
Unchecked |
Potency |
130.0 |
nM |
None |
| None |
Unchecked |
Protective effect |
18.0 |
% |
10.1021/jm00388a020 |
| None |
Unchecked |
Protective effect |
77.0 |
% |
10.1021/jm00388a020 |
| None |
Unchecked |
Protective effect |
97.0 |
% |
10.1021/jm00388a020 |
| None |
Unchecked |
Protective effect |
100.0 |
% |
10.1021/jm00388a020 |
| None |
Unchecked |
Ratio |
30.0 |
None |
10.1016/S0960-894X(97)00422-8 |
| None |
Unchecked |
Ratio |
133.0 |
None |
10.1021/np50082a020 |
| None |
Unchecked |
Ratio CC50/EC50 |
65.0 |
None |
10.1016/j.bmc.2011.07.023 |
| None |
Unchecked |
Ratio CC50/EC50 |
68.0 |
None |
10.1016/j.bmc.2012.04.030 |
| None |
Unchecked |
Ratio CC50/EC50 |
68.0 |
None |
10.1016/j.bmc.2012.07.026 |
| None |
Unchecked |
Ratio CC50/EC50 |
68.0 |
None |
10.1016/j.bmc.2013.09.009 |
| None |
Unchecked |
Ratio CC50/EC50 |
68.0 |
None |
10.1016/j.bmcl.2012.09.062 |
| None |
Unchecked |
Ratio CC50/EC50 |
74.0 |
None |
10.1016/j.bmc.2012.09.058 |
| None |
Unchecked |
Ratio CC50/EC50 |
74.0 |
None |
10.1016/j.bmcl.2012.09.062 |
| None |
Unchecked |
Ratio CC50/EC50 |
93.0 |
None |
10.1016/j.bmc.2012.09.058 |
| None |
Unchecked |
Ratio CC50/EC50 |
93.0 |
None |
10.1016/j.ejmech.2012.02.019 |
| None |
Unchecked |
Ratio CC50/EC50 |
108.0 |
None |
10.1016/j.ejmech.2011.08.011 |
| None |
Unchecked |
Ratio CC50/EC50 |
108.0 |
None |
10.1016/j.ejmech.2016.05.017 |
| None |
Unchecked |
Ratio CC50/EC50 |
127.0 |
None |
10.1016/j.ejmech.2011.08.011 |
| None |
Unchecked |
Ratio CC50/EC50 |
127.0 |
None |
10.1016/j.ejmech.2016.05.017 |
| None |
Unchecked |
Ratio CC50/EC50 |
169.0 |
None |
10.1039/C3MD00247K |
| None |
Unchecked |
Ratio CC50/EC50 |
208.0 |
None |
10.1016/j.bmc.2013.08.040 |
| None |
Unchecked |
Ratio CC50/EC50 |
nan |
None |
10.1016/j.bmc.2014.01.054 |
| None |
Unchecked |
Ratio CC50/IC50 |
108.0 |
None |
10.1007/s00044-013-0567-7 |
| None |
Unchecked |
Ratio CC50/IC50 |
127.0 |
None |
10.1007/s00044-013-0567-7 |
| None |
Unchecked |
Ratio CC50/IC50 |
248.73 |
None |
10.1016/j.bmc.2011.05.026 |
| None |
Unchecked |
Ratio CC50/IC50 |
266.7 |
None |
10.1016/j.bmc.2011.05.026 |
| None |
Unchecked |
Selectivity index |
8.0 |
SI |
10.1021/jm00170a015 |
| None |
Unchecked |
Selectivity index |
18.0 |
None |
10.1021/jm00047a013 |
| None |
Unchecked |
Selectivity index |
25.0 |
None |
10.1021/jm00081a015 |
| None |
Unchecked |
Selectivity index |
27.0 |
None |
10.1021/jm00047a013 |
| None |
Unchecked |
Selectivity index |
120.0 |
None |
10.1021/jm00081a015 |
| None |
Unchecked |
Selectivity ratio |
417.0 |
None |
10.1021/jm00170a016 |
| None |
Unchecked |
Selectivity ratio |
424.0 |
None |
10.1021/jm00170a016 |
| None |
Unchecked |
Selectivity ratio |
1304.0 |
None |
10.1021/jm00170a016 |
| None |
Unchecked |
Selectivity ratio |
1326.0 |
None |
10.1021/jm00170a016 |
| None |
Unchecked |
SI |
0.16 |
None |
10.1016/s0960-894x(01)00323-7 |
| None |
Unchecked |
SI |
4.4 |
None |
10.1021/jm00105a064 |
| None |
Unchecked |
SI |
7.3 |
None |
10.1021/jm00105a064 |
| None |
Unchecked |
SI |
23.0 |
None |
10.1016/S0960-894X(97)00001-2 |
| None |
Unchecked |
SI |
34.0 |
None |
10.1016/S0960-894X(97)00001-2 |
| None |
Unchecked |
SI |
133.0 |
None |
10.1021/jm00132a002 |
| None |
Unchecked |
SI |
1500.0 |
None |
10.1016/s0960-894x(02)00041-0 |
| None |
Unchecked |
SI |
nan |
None |
10.1016/s0960-894x(01)00323-7 |
| None |
Unchecked |
SI |
nan |
None |
10.1021/jm0309708 |